Board – Chairman
Michael D. Carr CFA — over 40 years experience in banking and equity, fixed income, real estate, and hedge fund portfolio management. For past 20 years active investor in angel capital companies.
Chief Executive Officer
Allison has 20+ years of diverse medical device, consumer and pharmaceutical experience in Healthcare. Leveraging her broad background in R&D, Marketing, Sales and Product Development, she has launched over 90 products/services.
Board – Member
Bill Perry has 29 years’ experience in VC & private equity medtech start-ups and growth companies. Bill has led or been a key part of fundraising efforts totaling ~$115M, is himself a seed stage investor, and has sat on multiple boards. He has been key parts of multiple successful exits (both acquisitions and IPO), and led 19 new medical product introductions, many from concept to regulatory approval (FDA, CE and Canada) through to market launch. He has consummated 20+ business development and licensing relationships. He has a BS from Georgetown University, and an MBA/MIM from ASU Thunderbird School of Global Management.
Board – Member
Frank B. Bennett, PhD – Forty years of experience as an entrepreneur and venture capitalist, with strengths in finance, capital formation, strategic planning, mergers and acquisitions. Twenty years of governance experience as a director and Chairman of private and public companies. From 1988 – 2010, President and CEO of Artesian Capital, a Minneapolis, MN private equity firm. Prior to that, Vice President of Piper, Jaffray as a health care investment banker and principal with Piper Jaffray Ventures.
Board – Advisor
Anne Whitaker has extensive life sciences industry experience, having worked across the pharmaceutical, biotech and specialty pharma sectors for the last thirty years. Anne previously held a number of senior executive roles at multiple public pharmaceutical companies Sanofi, GlaxoSmithKline, Bausch Health Company and Synta Pharmaceuticals, and, most recently, she held the position of Chief Executive Officer, and subsequently Chairperson of Aerami Therapeutics, a private life science company. Anne currently serves on the Boards of four public biopharmaceutical companies including Mallinckrodt, Faron Pharmaceuticals, OraSure Technologies and Caladrius Biosciences. Anne is recognized as a biopharma industry influencer, advisor and leader, having received numerous awards from PharmaVoice, Women Inc and Fierce Pharma. She holds a BS in Chemistry from University of North Alabama.
510(k) cleared for Hysteroscopy and Cystoscopy
Not for sale outside of the United States